Linking oxysterols and different stages of mild cognitive impairment: insights from gut metabolites and N6-methyladenosine
Abstract Background Oxysterols, gut metabolites, and N6-methyladenosine (m6A) are extensively implicated in the pathogenesis of cognitive dysfunction, while their alterations in different stages of mild cognitive impairment (MCI) have not been elucidated. Therefore, this study was conducted to explo...
Saved in:
| Main Authors: | Wenjing Feng, Mengwei Ju, Tao Wang, Shanshan Cui, Kexin Yang, Zhiting Guo, Miao Liu, Jiaxuan Tao, Huiyan Yu, Rong Xiao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Alzheimer’s Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13195-025-01743-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A panel of altered blood oxysterols in patients with mild cognitive impairment: A novel combined diagnostic marker
by: Yu An, et al.
Published: (2025-03-01) -
The Greek Version of the Mild Behavioral Impairment Checklist (MBI-C): Psychometric Properties in Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2025-04-01) -
Changes in selected oxysterols in powdered foodstuffs
by: Sylwia Chudy, et al.
Published: (2016-01-01) -
Olfactory Identification as a Biomarker for Cognitive Impairment: Insights from Healthy Aging, Subjective Cognitive Decline, and Mild Cognitive Impairment
by: Jaime Bouhaben, et al.
Published: (2024-11-01) -
Review of the prevalence of Mild Behavioral Impairment subdomains in populations from cognitively normal to Mild Cognitive Impairment according to International Society for Advanced Alzheimer's Research and Treatment criteria
by: Virginia Quicchi
Published: (2023-08-01)